Advertisement
U.S. Markets closed
S&P Futures
6,002.25 -1.50 (-0.02%) Dow Futures
43,899.00 -11.00 (-0.03%) Nasdaq Futures
21,223.50 -1.25 (-0.01%) Russell 2000 Futures
2,397.30 +1.60 (+0.07%) Crude Oil
71.89 -0.47 (-0.65%) Gold
2,703.90 -1.90 (-0.07%)
Stoke Therapeutics, Inc. (STOK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 13.25 |
| Open | 13.29 |
| Bid | 13.23 x 100 |
| Ask | 13.31 x 100 |
| Day's Range | 13.03 - 13.75 |
| 52 Week Range | 3.77 - 17.58 |
| Volume | |
| Avg. Volume | 528,038 |
| Market Cap | 702.872M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.08 |
| Earnings Date | Nov 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.29 |
Simply Wall St.Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
Stoke Therapeutics, Inc. ( NASDAQ:STOK ) shareholders will have a reason to smile today, with the analysts making...
ZacksStoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 9.62% and 41.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.